HEIQ WINS SWISS TECHNOLOGY AWARD 2020 FOR HEIQ VIROBLOCK NPJ03
HEIQ VIROBLOCK NPJ03 TEXTILE TECHNOLOGY TESTED EFFECTIVE AGAINST SARS-COV-2* – 99.99% REDUCTION OF THE COVID-19 CAUSING VIRUS
HeiQ Viroblock NPJ03 is among the first textile technologies in the world to be proven effective against SARS-CoV-2 by an independent institution*. SARS-CoV-2 is an enveloped virus from the coronavirus family that causes COVID-19.
Tests have been conducted by HeiQ with the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia (Doherty Institute).
HeiQ Viroblock is designed to inhibit the growth and persistence of bacteria and enveloped viruses on textile surfaces. It’s a unique combination of our registered silver technology for antiviral and antibacterial effect and our vesicle technology as a booster.
* M. J. (2020) Report on “Viral Stability and Persistence of SARS-CoV-2 on Treated Material”. Doherty Institute for Infection and Immunity, Melbourne.